$0.00
(Market cap
$5 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
0.5
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$-256 Mln
-
ROE
-49.4 %
-
ROCE
-- %
-
Industry P/E
32.57
-
EV/EBITDA
0.2
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$--
-
Face value
--
-
Shares outstanding
12,181,800
5 Years Aggregate
CFO
CN¥-796.80 Mln
EBITDA
CN¥-925.96 Mln
Net Profit
CN¥-997.97 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Molecular Data - ADR
| -99.9 | -82.9 | -99.6 | -100.0 | -- | -- | -- |
|
BSE Sensex*
| -9.1 | -1.2 | 2.9 | -3.6 | 5.7 | 6.2 | 10.5 |
|
Company
|
2021
|
2020
|
|---|---|---|
|
Molecular Data - ADR
| -74.0 | -82.4 |
|
BSE Sensex
| 22.0 | 15.8 |
|
BSE Sensex
| 22.0 | 15.8 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsAbout Molecular Data - ADR
Molecular Data Inc., through its subsidiaries, operates in the chemical e-commerce business in the People's Republic of China. The company operates technology-driven platform that connects participants along the chemical value chain through its... integrated solutions. It delivers e-commerce solutions, financial solutions, warehousing and logistics solutions, and software-as-a-service suites for participants in the traditional chemical industry. The company offers its e-commerce solutions through online platform that consists of molbase.com and molbase.cn websites; Moku Data Weixin account; Chemical Community app; and other ancillary platforms. Molecular Data Inc. was founded in 2013 and is headquartered in Shanghai, the People's Republic of China. Read more
-
CEO & CFO
Mr. Steven Foo
-
CEO & CFO
Mr. Steven Foo
-
Headquarters
Shanghai
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Molecular Data - ADR
What is the current share price of Molecular Data Inc - ADR Today?
The share price of Molecular Data Inc - ADR is $0.00 (NASDAQ) as of 08-Nov-2022 09:30 EDT. Molecular Data Inc - ADR has given a return of -99.96% in the last 1 years.
What is the current PB & PE ratio of Molecular Data Inc - ADR?
Since, TTM earnings of Molecular Data Inc - ADR is negative, P/E ratio is not available.
The P/B ratio of Molecular Data Inc - ADR is 0.54 times as on 11-Nov-2022, a 82 discount to its peers’ median range of 2.96 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2020 |
-14.97 |
-175.87 |
2019 |
-38.36 |
-34.29 |
2018 |
-- |
-- |
2017 |
-- |
-- |
2016 |
-- |
-- |
What is the 52 Week High and Low of Molecular Data Inc - ADR?
The 52-week high and low of Molecular Data Inc - ADR are Rs -- and Rs -- as of 31-Aug-2026.
What is the market cap of Molecular Data Inc - ADR?
Molecular Data Inc - ADR has a market capitalisation of $ 5 Mln as on 11-Nov-2022. As per SEBI classification, it is a company.
Should I invest in Molecular Data Inc - ADR?
Before investing in Molecular Data Inc - ADR, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.